Inactivated influenza vaccine (quadrivalent)

52 marketed 88 in Phase 3 9 in Phase 2

This page covers all Inactivated influenza vaccine (quadrivalent) drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting H5N1 influenza virus surface antigens (hemagglutinin and neuraminidase), H1N1 influenza virus hemagglutinin and neuraminidase antigens, Influenza virus.

Targets

H5N1 influenza virus surface antigens (hemagglutinin and neuraminidase) · H1N1 influenza virus hemagglutinin and neuraminidase antigens · Influenza virus · Influenza hemagglutinin (HA) protein · Influenza virus hemagglutinin and neuraminidase antigens; MF59 acts as immunological adjuvant · Influenza hemagglutinin (HA) antigens · Influenza B virus (Yamagata lineage) surface antigens · Influenza hemagglutinin and neuraminidase antigens · Influenza hemagglutinin (HA) antigen · Influenza virus surface antigens (hemagglutinin and neuraminidase)

Marketed (52)

Phase 3 pipeline (88)

Phase 2 pipeline (9)

Patent intelligence